CT-based Radiogenomics Framework for COVID-19 Using ACE2 Imaging Representations.

Coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 which enters the body via the angiotensin-converting enzyme 2 (ACE2) and altering its gene expression. Altered ACE2 plays a crucial role in the pathogenesis of COVID-19. Gene expression profiling, howeve...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Digital Imaging Vol. 36; no. 6; pp. 2356 - 2367
Autores principales: Xia, Tian, Fu, Xiaohang, Fulham, Michael, Wang, Yue, Feng, Dagan, Kim, Jinman
Formato: diagnostic images research tables/charts Journal Article
Publicado: Springer Nature Dec2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=173050949&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 173050949
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        08971889
        DOQ
      jtl: Journal of Digital Imaging
      issn: 08971889
      maglogo: N
    pubinfo:
      dt: Dec2023
      vid: 36
      iid: 6
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        173050949
        169824597
        173050949
        173050949
        10.1007/s10278-023-00895-w
        173050949
      ppf: 2356
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: CT-based Radiogenomics Framework for COVID-19 Using ACE2 Imaging Representations.
      aug:
        au:
          Xia, Tian
          Fu, Xiaohang
          Fulham, Michael
          Wang, Yue
          Feng, Dagan
          Kim, Jinman
        affil: https://ror.org/0384j8v12 School of Computer Science, Faculty of Engineering, The University of Sydney, 2006, Sydney, NSW, Australia
      sug:
        subj:
          COVID-19 Radiography
          COVID-19 Familial and Genetic
          Tomography, X-Ray Computed Methods
          Radiography Methods
          Genomics Methods
          Angiotensin-Converting Enzyme 2 Diagnostic Use
          Biological Markers Diagnostic Use
          Conceptual Framework
          Human
          Gene Expression Profiling
          Adenocarcinoma of Lung
          Gene Expression
          Severe Acute Respiratory Syndrome
          Multiple Logistic Regression
          Descriptive Statistics
          Experimental Studies
          COVID-19 Classification
          Critical Illness Risk Factors
          Risk Assessment
          Funding Source
      ab: Coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 which enters the body via the angiotensin-converting enzyme 2 (ACE2) and altering its gene expression. Altered ACE2 plays a crucial role in the pathogenesis of COVID-19. Gene expression profiling, however, is invasive and costly, and is not routinely performed. In contrast, medical imaging such as computed tomography (CT) captures imaging features that depict abnormalities, and it is widely available. Computerized quantification of image features has enabled 'radiogenomics', a research discipline that identifies image features that are associated with molecular characteristics. Radiogenomics between ACE2 and COVID-19 has yet to be done primarily due to the lack of ACE2 expression data among COVID-19 patients. Similar to COVID-19, patients with lung adenocarcinoma (LUAD) exhibit altered ACE2 expression and, LUAD data are abundant. We present a radiogenomics framework to derive image features (ACE2-RGF) associated with ACE2 expression data from LUAD. The ACE2-RGF was then used as a surrogate biomarker for ACE2 expression. We adopted conventional feature selection techniques including ElasticNet and LASSO. Our results show that: i) the ACE2-RGF encoded a distinct collection of image features when compared to conventional techniques, ii) the ACE2-RGF can classify COVID-19 from normal subjects with a comparable performance to conventional feature selection techniques with an AUC of 0.92, iii) ACE2-RGF can effectively identify patients with critical illness with an AUC of 0.85. These findings provide unique insights for automated COVID-19 analysis and future research.
      pubtype: Academic Journal
      doctype:
        diagnostic images
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N